Takeda completes Nycomed acquisition
OSAKA, Japan — Drug maker Takeda has completed its acquisition of another drug maker.
Takeda said that the deal, valued at $13 billion, is in line with the company’s 2011-2013 mid-range plan, and that Nycomed’s significant business infrastructure in Europe and high-growth emerging markets will enhance Takeda’s regulatory development expertise and commercialization capability.
In line with the acquisition, Takeda announced has named a new CEO for Nycomed. Frank Morich will lead Nycomed and also will continue to serve in his current role as EVP international operations of America/Europe at Takeda Pharmaceuticals International, which is a wholly-owned subsidiary of Takeda America Holdings.
"I look forward to bringing Takeda and Nycomed together to ensure we can achieve enhanced revenue, growth and diversification, while maintaining the strong momentum of both companies," Morich said. "The combined company significantly broadens our coverage of the global pharmaceutical market to more than 70 countries, increasing our global [prescription] sales ranking to 12th and further strengthening our position in the industry."
Stop & Shop opens third store in Cranston, R.I.
QUINCY, Mass. — Stop & Shop is opening the doors of its third store in Cranston, R.I., this weekend, the supermarket chain announced Friday.
"We value the relationship we have with our Cranston area customers and community partners and are pleased to open another store to help further serve the community," Stop & Shop New England division president Mark McGowan said.
The new store, which will pursue LEED certification in the coming months, was built with a range of energy-efficient features including:
New DuctSox (fabric duct) ventilation system — a first of its kind use for Stop & Shop — to provide more uniform airflow;
ECM motors in the refrigerated fixtures and walk-in coolers;
Low-mercury energy efficient T5 HO fluorescent light fixtures with occupancy sensors in the storage areas and offices;
LED lights for accent lighting (also in the refrigerated display cases and interior/exterior signage);
An energy management system to monitor the performance of the lighting, refrigeration, and HVAC systems; and
Low flow fixtures in the bathrooms and prep areas to reduce water consumption.
FDA declines to approve GSK vaccine
PHILADELPHIA — The Food and Drug Administration has declined to approve a vaccine developed by GlaxoSmithKline, the drug maker said.
GSK said it received a complete response letter from the FDA for MenHibrix (Hib-MenCY-TT), a vaccine for toddlers ages 6 weeks to 15 months against infection by Neisseria meningitides serogroups C and Y and Haemophilus influenza type b, also known as Hib. The FDA issues a complete response letter when it has finished reviewing an approval application for a drug or vaccine, but questions remain that preclude final approval; the company applying can resubmit once it has addressed the FDA’s questions.
The London-based company said this was the second complete response letter it had received from the FDA with regard to MenHibrix, though it did not specify which issues the agency had raised.